Aug 03, 2023

Study results indicate that family history of hereditary cancer syndrome appears to increase the risk for prostate cancer progression. Family history (FH) of malignancies, such as breast, ovari...

May 30, 2023

Christopher DiBlasio, MD, board-certified urologist and urologic surgeon, spoke with Physician’s Weekly about PMSA PET, an effective and precise technology for localizing metastatic prostate cancer....

May 08, 2023

We examine changes in the volume of patients with advanced prostate cancer and prescriptions for abiraterone and enzalutamide among urology practices with and without in-office dispensing.Using data f...

Jan 04, 2023

1. Fewer instances of clinically insignificant prostate cancer were identified in an experimental group receiving prostate MRI and targeted biopsy 2. Severe adverse events rare in both groups ...

Dec 19, 2022

Following a prostate cancer diagnosis, disease and treatment-related symptoms may result in diminished quality of life (QoL). Whether exercise improves QoL in men with metastatic castrate-resistant pr...

Dec 05, 2022

The objective of our study was to evaluate the detection rate of prostate cancer by digital rectal examination (DRE) and serum prostate-specific antigen (PSA) levels followed by standard 12-core trans...

Dec 05, 2022

The objective of our study was to evaluate the detection rate of prostate cancer by digital rectal examination (DRE) and serum prostate-specific antigen (PSA) levels followed by standard 12-core trans...

Dec 05, 2022

The objective of our study was to evaluate the detection rate of prostate cancer by digital rectal examination (DRE) and serum prostate-specific antigen (PSA) levels followed by standard 12-core trans...

Oct 10, 2022

With outside influences like the Internet, distinguishing between men who are dealing with the normal symptoms of aging and men who have hypogonadism can be challenging. Although testosterone r...

Jul 20, 2022

The IsoPSA biomarker displays superior diagnostic accuracy in the early detection of prostate cancer, thereby helping to avoid unnecessary prostate biopsies. There is a growing population of pa...

Mar 07, 2022

Current therapeutic developments in prostate cancer (PCa) tend to increasingly personalize the treatment strategy, in particular as a function of tumor genomics. Recently, poly ADP-ribose polymerase (...

Oct 04, 2021

The role of the Urology Specialist Therapeutic Radiographer (USTR) was introduced to support a busy NHS uro-oncology practice. Key objectives were to improve patient preparedness for and experience of...

Aug 12, 2021

The objective of this study is to investigate the clinical significance and risk factors of upgrading in the International Society of Urological Pathology (ISUP) Grade Group System in men undergoing r...

May 31, 2021

“Whenever a new medical technology is introduced—such as prostatic urethral lift (PUL) for benign prostatic enlargement and lower urinary tract symptoms (BPE/LUTS)—it is important to understand ...

May 03, 2021

To update the Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer, the same panelists as in the previous consensus pan...

Mar 22, 2021

Recent approvals of second-generation androgen receptor inhibitors (SGARIs) have changed the treatment landscape for non-metastatic castration-resistant prostate cancer (nmCRPC). These SGARIs have sim...

Mar 01, 2021

Propose an approach of prostate cancer (PCa) patients during COVID-19 pandemic.We conducted a review of current literature related to surgical and clinical management of patients during COVID-19 crisi...

Mar 01, 2021

The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients w...

Mar 01, 2021

The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients wi...

Feb 25, 2020

Histopathological discrepancies between biopsy and radical prostatectomy (RP) specimens may lead to unnecessary, excessive, or incomplete treatment in prostate cancer (PCa) patients.To compare the upg...